Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12445294 | 0.90 | ALDH1A1 (0.46) | ALDH1A1LMNAHSD17B10CHRM5CHRM1 | |
| SCHEMBL5704616 | 0.86 | ALDH1A1 (0.39) | ALDH1A1LMNAHSD17B10CHRM5CHRM1 | |
| SCHEMBL14715844 | 0.84 | ALDH1A1 (0.37) | ALDH1A1LMNAHSD17B10CHRM5CHRM1 | |
| SCHEMBL16213957 | 0.83 | ALDH1A1 (0.40) | ALDH1A1LMNAHSD17B10CHRM5CHRM1 | |
| SCHEMBL20258482 | 0.82 | THRB (0.37) | ALDH1A1LMNAHSD17B10CHRM5CHRM1 | |
| SCHEMBL17832176 | 0.82 | ALDH1A1 (0.33) | ALDH1A1LMNAHSD17B10 | |
| SCHEMBL14281229 | 0.81 | HTT (0.32) | HTT | |
| SCHEMBL333504 | 0.79 | — | — | |
| SCHEMBL610647 | 0.79 | HTT (0.37) | ALDH1A1HTT | |
| SCHEMBL6876173 | 0.79 | ALDH1A1 (0.46) | ALDH1A1LMNAHSD17B10CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9427777-B2 | Process for producing charge retention medium | ASAHI GLASS COMPANY, LIMITED (JP) | 2016-08-30 | — | — | US | claimed |
| US-7195752-B2 | Surfactant compounds and uses thereof | GLAXO GROUP LIMITED (GB) | 2007-03-27 | — | — | US | claimed |
| EP-1486203-A2 | Surfactant compounds and uses thereof | GLAXO GROUP LIMITED (GB) | 2004-12-15 | — | — | EP | claimed |
| US-20040234556-A1 | Surfactant compounds and uses thereof | GLAXO GROUP LIMITED (GB) | 2004-11-25 | — | — | US | claimed |
| EP-1411896-A2 | SURFACTANT COMPOUNDS AND USES THEREOF | GLAXO GROUP LIMITED (GB) | 2004-04-28 | — | — | EP | claimed |
| WO-2003013610-A2 | SURFACTANT COMPOUNDS AND USES THEREOF | GLAXO GROUP LIMITED (GB) | 2003-02-20 | — | — | WO | claimed |
| US-20250239647-A1 | COMPOSITE SOLID ELECTROLYTE AND SECONDARY BATTERY INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-07-24 | — | — | US | disclosed |
| US-20220123241-A1 | PREPARATION AND LAYER | NeuDrive Llimited (GB) | 2022-04-21 | — | — | US | disclosed |
| US-9427777-B2 | Process for producing charge retention medium | ASAHI GLASS COMPANY, LIMITED (JP) | 2016-08-30 | — | — | US | disclosed |
| US-20150221987-A1 | ELECTROLYTIC SOLUTION FOR NON-AQUEOUS SECONDARY BATTERY, AND NON-AQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY | FUJIFILM CORPORATION (JP) | 2015-08-06 | — | — | US | disclosed |
| EP-2648196-A1 | CHARGE RETENTION MEDIUM | Asahi Glass Company, Limited (JP) | 2013-10-09 | — | — | EP | disclosed |
| EP-2648197-A1 | METHOD FOR PRODUCING CHARGE RETENTION MEDIUM | Asahi Glass Company, Limited (JP) | 2013-10-09 | — | — | EP | disclosed |
| US-20130261248-A1 | CHARGE RETENTION MEDIUM | ASAHI GLASS COMPANY, LIMITED (JP) | 2013-10-03 | — | — | US | disclosed |
| US-7544706-B2 | Substituted imidazoles | PFIZER LIMITED (GB) | 2009-06-09 | — | — | US | disclosed |
| WO-2008121804-A1 | USE OF A COMBINATION CHAIN TRANSFER AND ACTIVATING AGENT TO CONTROL MOLECULAR WEIGHT AND OPTICAL DENSITY OF PD CATALYZED NORBORNENE POLYMERS | PROMERUS LLC (US) | 2008-10-09 | — | — | WO | disclosed |
| US-20080125473-A1 | SUBSTITUTED IMIDAZOLES | PFIZER LIMITED (GB) | 2008-05-29 | — | — | US | disclosed |
| US-20080119536-A1 | SUBSTITUTED IMIDAZOLES | PFIZER LIMITED (GB) | 2008-05-22 | — | — | US | disclosed |
| US-20080004415-A1 | Non-linear optically active molecules, their synthesis, and use | OPTIMER PHOTONICS, INC. (US) | 2008-01-03 | — | — | US | disclosed |
| US-20070167506-A1 | SUBSTITUTED IMIDAZOLES | PFIZER INC. (US) | 2007-07-19 | — | — | US | disclosed |
| US-20070088029-A1 | Tricycloundecane compounds useful as modulators of nuclear hormone receptor function | BRISTOL-MYERS SQUIBB COMPANY | 2007-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080125473-A1 | SUBSTITUTED IMIDAZOLES | ABL1, TYR, CYP3A4 | ALDH1A1 617/4885LMNA 3030/4885HSD17B10 4048/4885 |
| US-20070167506-A1 | SUBSTITUTED IMIDAZOLES | ABL1, TYR, CYP3A4 | ALDH1A1 617/4885LMNA 3030/4885HSD17B10 4048/4885 |
| US-20080119536-A1 | SUBSTITUTED IMIDAZOLES | ABL1, TYR, CYP3A4 | ALDH1A1 617/4885LMNA 3030/4885HSD17B10 4048/4885 |
| US-20040234556-A1 | Surfactant compounds and uses thereof | PFN1, SGMS1, SPTLC1 | ALDH1A1 1123/4885LMNA 836/4885HSD17B10 1541/4885 |
| US-20070088029-A1 | Tricycloundecane compounds useful as modulators of nuclear hormone receptor function | VDR, ESRRB, NR5A1 | ALDH1A1 3634/4885LMNA 3299/4885HSD17B10 94/4885 |
| US-20080004415-A1 | Non-linear optically active molecules, their synthesis, and use | INCENP, CYBA, PAICS | ALDH1A1 378/4885LMNA 289/4885HSD17B10 1611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.